Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Childs

Showing results (121-130 of 151) with videos related to

Pageof 16
Sort By:
European Urology Open Science|July 23, 2024
Survival Patterns Based on First-site-specific Visceral Metastatic Prostate Cancer: Are Outcomes of Visceral Metastases the Same?Mohamed E Ahmed, Ahmed M Mahmoud, Guiseppe Reitano, et al.
Cancers|June 26, 2025
Race and Outcomes to [<sup>177</sup>Lu]Lu-PSMA-617 in Advanced Prostate CancerAvina Rami, Caiwei Zhong, Miguel Muniz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancerMary L Disis, Danelle R Wallace, Theodore A Gooley, et al.
Prostate Cancer and Prostatic Diseases|November 7, 2023
Early PSA decline after starting second-generation hormone therapy in the post-docetaxel setting predicts cancer-specific survival in metastatic castrate-resistant prostate cancerMohamed E Ahmed, Matthew S Lee, Ahmed M Mahmoud, et al.
JAMA Oncology|March 2, 2023
First-line Systemic Treatment Options for Metastatic Castration-Sensitive Prostate Cancer: A Living Systematic Review and Network Meta-analysisIrbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, Huan He, et al.
Cancer Treatment Reviews|April 16, 2025
Current and future directions in theranostics for neuroendocrine prostate cancerGokce Belge Bilgin, Fabrice Lucien-Matteoni, Aadel A Chaudhuri, et al.
Cancers|September 27, 2025
Evolution of Potentially Actionable Genomic Alterations in Advanced Prostate Cancer: A Real-World Analysis of Serial Circulating Tumor DNA TestingMiguel Muniz, L Jill Tsai, Jacob J Orme, et al.
European Urology|May 27, 2025
Consolidative Surgery for Advanced Urothelial Carcinoma Following Induction Enfortumab Vedotin and/or Immune Checkpoint Inhibitor Therapy: A Multicenter AnalysisDaniel S Roberson, Vidit Sharma, Stephen A Boorjian, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2024
Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [<sup>177</sup>Lu]Lu-PSMA-617Miguel Muniz, Oliver Sartor, Jacob J Orme, et al.
BJU International|November 30, 2024
In-field prostate cancer recurrence following radical prostatectomy and salvage radiationAustin Martin, Ahmed M Mahmoud, Cameron J Britton, et al.
Pageof 16

Showing results (121-130 of 151) with videos related to

Sort By:
Pageof 16
European Urology Open Science|July 23, 2024
Survival Patterns Based on First-site-specific Visceral Metastatic Prostate Cancer: Are Outcomes of Visceral Metastases the Same?Mohamed E Ahmed, Ahmed M Mahmoud, Guiseppe Reitano, et al.
Cancers|June 26, 2025
Race and Outcomes to [<sup>177</sup>Lu]Lu-PSMA-617 in Advanced Prostate CancerAvina Rami, Caiwei Zhong, Miguel Muniz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancerMary L Disis, Danelle R Wallace, Theodore A Gooley, et al.
Prostate Cancer and Prostatic Diseases|November 7, 2023
Early PSA decline after starting second-generation hormone therapy in the post-docetaxel setting predicts cancer-specific survival in metastatic castrate-resistant prostate cancerMohamed E Ahmed, Matthew S Lee, Ahmed M Mahmoud, et al.
JAMA Oncology|March 2, 2023
First-line Systemic Treatment Options for Metastatic Castration-Sensitive Prostate Cancer: A Living Systematic Review and Network Meta-analysisIrbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, Huan He, et al.
Cancer Treatment Reviews|April 16, 2025
Current and future directions in theranostics for neuroendocrine prostate cancerGokce Belge Bilgin, Fabrice Lucien-Matteoni, Aadel A Chaudhuri, et al.
Cancers|September 27, 2025
Evolution of Potentially Actionable Genomic Alterations in Advanced Prostate Cancer: A Real-World Analysis of Serial Circulating Tumor DNA TestingMiguel Muniz, L Jill Tsai, Jacob J Orme, et al.
European Urology|May 27, 2025
Consolidative Surgery for Advanced Urothelial Carcinoma Following Induction Enfortumab Vedotin and/or Immune Checkpoint Inhibitor Therapy: A Multicenter AnalysisDaniel S Roberson, Vidit Sharma, Stephen A Boorjian, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2024
Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [<sup>177</sup>Lu]Lu-PSMA-617Miguel Muniz, Oliver Sartor, Jacob J Orme, et al.
BJU International|November 30, 2024
In-field prostate cancer recurrence following radical prostatectomy and salvage radiationAustin Martin, Ahmed M Mahmoud, Cameron J Britton, et al.
Pageof 16